140 related articles for article (PubMed ID: 20356496)
21. Can patients at high risk for significant colorectal neoplasms and having normal quantitative faecal occult blood test postpone elective colonoscopy?
Hazazi R; Rozen P; Leshno M; Levi Z; Samuel Z; Waked A; Vilkin A; Maoz E; Birkenfeld S; Niv Y
Aliment Pharmacol Ther; 2010 Feb; 31(4):523-33. PubMed ID: 19925498
[TBL] [Abstract][Full Text] [Related]
22. [Comparison of three FOBT protocols for colorectal cancer screening in Chinese--a multicenter study].
Li SR; Wang HH; Hu JC; Li N; Liu YL; Wu ZT; Zheng Y; Wang HH; Wu K; Ye H
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(10):697-700. PubMed ID: 15932737
[TBL] [Abstract][Full Text] [Related]
23. Screening colonoscopy and fecal occult blood testing practice patterns: a population-based survey of gastroenterologists.
Rossi F; Sosa JA; Aslanian HR
J Clin Gastroenterol; 2008; 42(10):1089-94. PubMed ID: 18936643
[TBL] [Abstract][Full Text] [Related]
24. Better acceptance of Fecal Occult Blood Test (FOBT) for colorectal cancer screening during hospitalization.
Keller R; Schätzle A; Flieger D; Christl SU; Fischbach W
Z Gastroenterol; 2003 Jul; 41(7):655-8. PubMed ID: 12858236
[TBL] [Abstract][Full Text] [Related]
25. Validation of self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans.
Partin MR; Grill J; Noorbaloochi S; Powell AA; Burgess DJ; Vernon SW; Halek K; Griffin JM; van Ryn M; Fisher DA
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):768-76. PubMed ID: 18381474
[TBL] [Abstract][Full Text] [Related]
26. High participation rates are not necessary for cost-effective colorectal cancer screening.
Howard K; Salkeld G; Irwig L; Adelstein BA
J Med Screen; 2005; 12(2):96-102. PubMed ID: 15949121
[TBL] [Abstract][Full Text] [Related]
27. Screening for gastrointestinal neoplasia: efficacy and cost of two different approaches in a clinical rehabilitation centre.
Manus B; Brägelmann R; Armbrecht U; Stolte M; Stockbrügger RW
Eur J Cancer Prev; 1996 Feb; 5(1):49-55. PubMed ID: 8664809
[TBL] [Abstract][Full Text] [Related]
28. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer.
Parente F; Marino B; DeVecchi N; Moretti R; ; Ucci G; Tricomi P; Armellino A; Redaelli L; Bargiggia S; Cristofori E; Masala E; Tortorella F; Gattinoni A; Odinolfi F; Pirola ME
Br J Surg; 2009 May; 96(5):533-40. PubMed ID: 19358181
[TBL] [Abstract][Full Text] [Related]
29. Screening of colorectal cancer.
Winawer SJ
Surg Oncol Clin N Am; 2005 Oct; 14(4):699-722. PubMed ID: 16226687
[TBL] [Abstract][Full Text] [Related]
30. [Randomized controlled trial of sequence mass screening program for colorectal cancer].
Liu X; Zheng S; Chen K; Ma X; Zhou L; Yu H; Yao K; Chen K; Cai S; Zhang S
Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Dec; 21(6):430-3. PubMed ID: 11860828
[TBL] [Abstract][Full Text] [Related]
31. Colorectal cancer screening: physician attitudes and practices.
Taylor ML; Anderson R
WMJ; 2002; 101(5):39-43. PubMed ID: 12239980
[TBL] [Abstract][Full Text] [Related]
32. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
33. Are we doing enough to screen for colorectal cancer? Findings from the 1999 Behavioral Risk Factor Surveillance System.
Seeff LC; Shapiro JA; Nadel MR
J Fam Pract; 2002 Sep; 51(9):761-6. PubMed ID: 12366896
[TBL] [Abstract][Full Text] [Related]
34. [Features of colorectal cancer with fecal-occult-blood tests--comparison with colorectal cancer with no screening].
Takemasa I; Kikkawa N; Yasui M; Nishisho I; Fujitani K; Mishima H; Hasuike Y; Kobayashi K
Gan To Kagaku Ryoho; 1998 Aug; 25(10):1514-8. PubMed ID: 9725042
[TBL] [Abstract][Full Text] [Related]
35. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population.
Morikawa T; Kato J; Yamaji Y; Wada R; Mitsushima T; Shiratori Y
Gastroenterology; 2005 Aug; 129(2):422-8. PubMed ID: 16083699
[TBL] [Abstract][Full Text] [Related]
36. Cost-effectiveness analysis of the optimal threshold of an automated immunochemical test for colorectal cancer screening: performances of immunochemical colorectal cancer screening.
Berchi C; Guittet L; Bouvier V; Launoy G
Int J Technol Assess Health Care; 2010 Jan; 26(1):48-53. PubMed ID: 20059780
[TBL] [Abstract][Full Text] [Related]
37. Colorectal cancer screening among first-degree relatives of colorectal cancer patients: benefits and barriers.
Mack LA; Cook LS; Temple WJ; Carlson LE; Hilsden RJ; Paolucci EO
Ann Surg Oncol; 2009 Aug; 16(8):2092-100. PubMed ID: 19479307
[TBL] [Abstract][Full Text] [Related]
38. [Prevention and early detection of colorectal cancer in average risk population--summary of a meeting and the Israeli gastroenterology policy].
Strul H; Elyakim R; Halpern Z; Arber N
Harefuah; 2003 Mar; 142(3):223-6, 236. PubMed ID: 12696479
[TBL] [Abstract][Full Text] [Related]
39. Colonoscopy results of a French regional FOBT-based colorectal cancer screening program with high compliance.
Manfredi S; Piette C; Durand G; Plihon G; Mallard G; Bretagne JF
Endoscopy; 2008 May; 40(5):422-7. PubMed ID: 18231963
[TBL] [Abstract][Full Text] [Related]
40. Colorectal cancer screening in Canada: results of a national survey.
Sewitch MJ; Fournier C; Ciampi A; Dyachenko A
Chronic Dis Can; 2008; 29(1):9-21. PubMed ID: 19036219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
